Risk of glaucoma after early bilateral oophorectomy

Menopause

Volumn 21, Issue 4, 2014, Pages 391-398

  Vajaranant, Thasarat S ^a,b   Grossardt, Brandon R ^b   Maki, Pauline M ^a   Pasquale, Louis R ^c   Sit, Arthur J ^b   Shuster, Lynne T ^b   Rocca, Walter A ^b  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b MAYO CLINIC   (United States)

^c CHANNING LABORATORY   (United States)

Author keywords

Aging; Estrogen; Glaucoma; Hormone therapy; Menopause; Oophorectomy

Indexed keywords

ESTROGEN;

ADULT; AGE; AGE DISTRIBUTION; ARTICLE; BILATERAL OOPHORECTOMY; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISORDERS OF LIPID METABOLISM; EARLY INTERVENTION; EARLY MENOPAUSE; ESTROGEN DEFICIENCY; ESTROGEN THERAPY; FEMALE; FOLLOW UP; GLAUCOMA; HAZARD RATIO; HIGH RISK PATIENT; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; MENARCHE; MIDDLE AGED; OBESITY; OUTCOME ASSESSMENT; OVARIECTOMY; PREDICTIVE VALUE; RISK ASSESSMENT; RISK FACTOR; VALIDATION STUDY; AGING; DEFICIENCY; PROPORTIONAL HAZARDS MODEL;

ADULT; AGE FACTORS; AGING; COHORT STUDIES; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; FEMALE; GLAUCOMA; HUMANS; MIDDLE AGED; OVARIECTOMY; PROPORTIONAL HAZARDS MODELS; RISK FACTORS;

EID: 84897525737     PISSN: 10723714     EISSN: 15300374     Source Type: Journal    
DOI: 10.1097/GME.0b013e31829fd081     Document Type: Article

References (52)

1. Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol 2006;90:262-267.
2. Vajaranant TS, Nayak S, Wilensky JT, Joslin CE. Gender and glaucoma: what we know and what we need to know. Curr Opin Ophthalmol 2010;21:91-99.
3. Varma R, Lee PP, Goldberg I, Kotak S. An assessment of the health and economic burdens of glaucoma. Am J Ophthalmol 2011;152:515-522.
4. Ramulu P. Glaucoma and disability: which tasks are affected, and at what stage of disease? Curr Opin Ophthalmol 2009;20:92-98.
5. Vajaranant TS, Wu S, Torres M, Varma R. The changing face of primary open-angle glaucoma in the United States: demographic and geographic changes from 2011 to 2050. Am J Ophthalmol 2012;154:303.e3-314.e3.
6. Guedes G, Tsai JC, Loewen NA. Glaucoma and aging. Curr Aging Sci 2011; 4:110-117.
7. Tezel G, Luo C, Yang X. Accelerated aging in glaucoma: immunohistochemical assessment of advanced glycation end products in the human retina and optic nerve head. Invest Ophthalmol Vis Sci 2007;48:1201-1211.
8. Vajaranant TS, Pasquale LR. Estrogen deficiency accelerates aging of the optic nerve. Menopause 2012;19:942-947.
9. Weinreb RN, Khaw PT. Primary open-angle glaucoma. Lancet 2004;363: 1711-1720.
10. Ryskulova A, Turczyn K, Makuc DM, Cotch MF, Klein RJ, Janiszewski R. Self-reported age-related eye diseases and visual impairment in the United States: results of the 2002 national health interview survey. Am J Public Health 2008;98:454-461.
11. Friedman DS, Nordstrom B, Mozaffari E, Quigley HA. Variations in treatment among adult-onset open-angle glaucoma patients. Ophthalmology 2005;112:1494-1499.
12. Hulsman CA, Westendorp IC, Ramrattan RS, et al. Is open-angle glaucoma associated with early menopause? The Rotterdam Study. Am J Epidemiol 2001;154:138-144.
13. Nirmalan PK, Katz J, Robin AL, et al. Female reproductive factors and eye disease in a rural South Indian population: the Aravind Comprehensive Eye Survey. Invest Ophthalmol Vis Sci 2004;45:4273-4276.
14. Pasquale LR, Kang JH. Female reproductive factors and primary openangle glaucoma in the Nurses' Health Study. Eye 2011;25:633-641.
15. Pasquale LR, Rosner BA, Hankinson SE, Kang JH. Attributes of female reproductive aging and their relation to primary open-angle glaucoma: a prospective study. J Glaucoma 2007;16:598-605.
16. Lee AJ, Mitchell P, Rochtchina E, Healey PR. Female reproductive factors and open angle glaucoma: the Blue Mountains Eye Study. Br J Ophthalmol 2003;87:1324-1328.
17. Deschenes MC, Descovich D, Moreau M, et al. Postmenopausal hormone therapy increases retinal blood flow and protects the retinal nerve fiber layer. Invest Ophthalmol Vis Sci 2010;51:2587-2600.
18. Russo R, Cavaliere F, Watanabe C, et al. 17A-Estradiol prevents retinal ganglion cell loss induced by acute rise of intraocular pressure in rat. Prog Brain Res 2008;173:583-590.
19. Zhou X, Li F, Ge J, et al. Retinal ganglion cell protection by 17-A-estradiol in a mouse model of inherited glaucoma. Dev Neurobiol 2007;67:603-616.
20. Rocca WA, Bower JH, Maraganore DM, et al. Increased risk of cognitive impairment or dementia in women who underwent oophorectomy before menopause. Neurology 2007;69:1074-1083.
21. Rocca WA, Bower JH, Maraganore DM, et al. Increased risk of parkinsonism in women who underwent oophorectomy before menopause. Neurology 2008;70:200-209.
22. Rocca WA, Grossardt BR, de Andrade M, Malkasian GD, Melton LJ III. Survival patterns after oophorectomy in premenopausal women: a population-based cohort study. Lancet Oncol 2006;7:821-828.
23. Rocca WA, Grossardt BR, Geda YE, et al. Long-term risk of depressive and anxiety symptoms after early bilateral oophorectomy. Menopause 2008;15:1050-1059.
24. Rivera CM, Grossardt BR, Rhodes DJ, et al. Increased cardiovascular mortality after early bilateral oophorectomy. Menopause 2009;16:15-23.
25. St Sauver JL, Grossardt BR, Yawn BP, et al. Data resource profile: the Rochester Epidemiology Project (REP) medical records-linkage system. Int J Epidemiol 2012;41:1614-1624.
26. St Sauver JL, Grossardt BR, Leibson CL, Yawn BP, Melton LJ III, Rocca WA. Generalizability of epidemiologic findings and public health decisions: an illustration from the Rochester Epidemiology Project. Mayo Clin Proc 2012;87:151-160.
27. Rocca WA, Yawn BP, St Sauver JL, Grossardt BR, Melton LJ. History of the Rochester Epidemiology Project: half a century of medical records linkage in a US population. Mayo Clin Proc 2012;87:1202-1213.
28. St Sauver JL, Grossardt BR, Yawn BP, Melton LJ III, Rocca WA. Use of a medical records linkage system to enumerate a dynamic population over time: the Rochester Epidemiology Project. Am J Epidemiol 2011; 173:1059-1068.
29. Agency for Healthcare Research and Quality. Medical Expenditure Panel Survey HC-120. Appendix 3: Clinical Classification Software (CCS) to ICD-9-CM Code Crosswalk. Available at: http://meps.ahrq.gov/mepsweb/data-stats/download- data/pufs/h120/h120-icd9codes.shtml. Accessed May 20, 2013.
30. Agency for Healthcare Research and Quality. Healthcare Cost and Utilization Project Clinical Classification Software (CCS) for ICD-9-CM. Available at: www.hcup-us.ahrq.gov/toolssoftware/ccs/ccs.jsp. Updated August 30, 2012. Accessed May 20, 2013.
31. Rocca WA, Grossardt BR, Shuster LT. Oophorectomy, menopause, estrogen treatment, and cognitive aging: clinical evidence for a window of opportunity. Brain Res 2011;1379:188-198.
32. Altintas O, Caglar Y, Yuksel N, Demirci A, Karabas L. The effects of menopause and hormone replacement therapy on quality and quantity of tear, intraocular pressure and ocular blood flow. Ophthalmologica 2004; 218:120-129.
33. Ogueta SB, Schwartz SD, Yamashita CK, Farber DB. Estrogen receptor in the human eye: influence of gender and age on gene expression. Invest Ophthalmol Vis Sci 1999;40:1906-1911.
34. Tint NL, Alexander P, Tint KM, Vasileiadis GT, Yeung AM, Azuara-Blanco A. Hormone therapy and intraocular pressure in nonglaucomatous eyes. Menopause 2010;17:157-160.
35. Sator MO, Akramian J, Joura EA, et al. Reduction of intraocular pressure in a glaucoma patient undergoing hormone replacement therapy. Maturitas 1998;29:93-95.
36. Sator MO, Joura EA, Frigo P, et al. Hormone replacement therapy and intraocular pressure. Maturitas 1997;28:55-58.
37. Toker E, Yenice O, Temel A. Influence of serum levels of sex hormones on intraocular pressure in menopausal women. J Glaucoma 2003;12: 436-440.
38. Harris A, Rechtman E, Siesky B, Jonescu-Cuypers C, McCranor L, Garzozi HJ. The role of optic nerve blood flow in the pathogenesis of glaucoma. Ophthalmol Clin North Am 2005;18:345-353.
39. Feke GT, Pasquale LR. Retinal blood flow response to posture change in glaucoma patients compared with healthy subjects. Ophthalmology 2008;115:246-252.
40. Kang JH, Wiggs JL, Rosner BA, et al. Endothelial nitric oxide synthase gene variants and primary open-angle glaucoma: interactions with sex and postmenopausal hormone use. Invest Ophthalmol Vis Sci 2010; 51:971-979.
41. Ohmichi M, Kanda Y, Hisamoto K, et al. Rapid changes of flowmediated dilatation after surgical menopause. Maturitas 2003;44:125-131.
42. Harris-Yitzhak M, Harris A, Ben-Refael Z, Zarfati D, Garzozi HJ, Martin BJ. Estrogen-replacement therapy: effects on retrobulbar hemodynamics. Am J Ophthalmol 2000;129:623-628.
43. Harris A, Harris M, Biller J, et al. Aging affects the retrobulbar circulation differently in women and men. Arch Ophthalmol 2000;118: 1076-1080.
44. Atalay E, Karaali K, Akar M, et al. Early impact of hormone replacement therapy on vascular hemodynamics detected via ocular colour Doppler analysis. Maturitas 2005;50:282-288.
45. Atilla H, Arslanpence A, Batioglu F, et al. Effect of hormone replacement therapy on ocular hemodynamics in postmenopausal women. Eur J Ophthalmol 2001;11:277-280.
46. Battaglia C, Mancini F, Regnani G, Persico N, Volpe A, De Aloysio D. Hormone therapy and ophthalmic artery blood flow changes in women with primary open-angle glaucoma. Menopause 2004;11:69-77.
47. Park BJ, Park JO, Kang HT, Lee YJ. Elevated intraocular pressure is associated with metabolic syndrome in postmenopausal women: the Korean National Health and Nutrition Examination Survey. Menopause 2013;20:742-746.
48. Atsma F, Bartelink ML, Grobbee DE, van der Schouw YT. Postmenopausal status and early menopause as independent risk factors for cardiovascular disease: a meta-analysis. Menopause 2006;13:265-279.
49. Pasquale LR. There is more to the relation between intraocular pressure and metabolic syndrome than meets the eye: a connection to estrogen deficiency. Menopause 2013;20:719-720.
50. Porta MS. International Epidemiological Association. A Dictionary of Epidemiology, 5th ed. Oxford, England: Oxford University Press; 2008.
51. Shuster LT, Rhodes DJ, Gostout BS, Grossardt BR, Rocca WA. Premature menopause or early menopause: long-term health consequences. Maturitas 2010;65:161-166.
52. Rocca WA, Ulrich LG. Oophorectomy for whom and at what age? Primum non nocere (Editorial). Maturitas 2012;71:1-2.